Institutional & Family Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$346K Buy
2,020
+412
+26% +$70.7K 0.05% 125
2024
Q1
$293K Sell
1,608
-84
-5% -$15.3K 0.05% 127
2023
Q4
$262K Buy
1,692
+19
+1% +$2.95K 0.04% 131
2023
Q3
$249K Buy
1,673
+21
+1% +$3.13K 0.04% 130
2023
Q2
$223K Sell
1,652
-4
-0.2% -$539 0.04% 137
2023
Q1
$264K Buy
1,656
+197
+14% +$31.4K 0.04% 129
2022
Q4
$236K Sell
1,459
-89
-6% -$14.4K 0.04% 131
2022
Q3
$208K Sell
1,548
-148
-9% -$19.9K 0.04% 133
2022
Q2
$260K Sell
1,696
-206
-11% -$31.6K 0.04% 124
2022
Q1
$308K Buy
1,902
+12
+0.6% +$1.94K 0.05% 128
2021
Q4
$256K Sell
1,890
-38
-2% -$5.15K 0.04% 141
2021
Q3
$208K Buy
1,928
+125
+7% +$13.5K 0.03% 170
2021
Q2
$203K Sell
1,803
-515
-22% -$58K 0.03% 171
2021
Q1
$251K Buy
2,318
+70
+3% +$7.58K 0.05% 158
2020
Q4
$241K Sell
2,248
-76
-3% -$8.15K 0.05% 164
2020
Q3
$204K Sell
2,324
-2,630
-53% -$231K 0.05% 164
2020
Q2
$486K Buy
4,954
+1,305
+36% +$128K 0.1% 111
2020
Q1
$278K Buy
3,649
+545
+18% +$41.5K 0.06% 128
2019
Q4
$275K Sell
3,104
-542
-15% -$48K 0.06% 143
2019
Q3
$276K Buy
3,646
+909
+33% +$68.8K 0.06% 137
2019
Q2
$199K Sell
2,737
-16
-0.6% -$1.16K 0.04% 166
2019
Q1
$222K Buy
2,753
+3
+0.1% +$242 0.05% 170
2018
Q4
$253K Sell
2,750
-1,161
-30% -$107K 0.06% 146
2018
Q3
$370K Sell
3,911
-1,762
-31% -$167K 0.07% 143
2018
Q2
$526K Buy
5,673
+1,320
+30% +$122K 0.11% 108
2018
Q1
$412K Buy
4,353
+150
+4% +$14.2K 0.09% 122
2017
Q4
$406K Sell
4,203
-26
-0.6% -$2.51K 0.08% 122
2017
Q3
$376K Buy
4,229
+240
+6% +$21.3K 0.08% 136
2017
Q2
$289K Buy
3,989
+110
+3% +$7.97K 0.07% 112
2017
Q1
$253K Buy
+3,879
New +$253K 0.08% 113
2016
Q3
Sell
-3,585
Closed -$222K 117
2016
Q2
$222K Buy
+3,585
New +$222K 0.08% 110